Cargando…
IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA
PURPOSE: Posterior fossa ependymomas (PFE) are common pediatric brain tumors often assessed with MRI before surgery. Advanced radiomic analysis show promise in stratifying risk and outcome in other pediatric brain tumors. Here, we extracted high-dimensional MRI features to identify prognostic, image...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715588/ http://dx.doi.org/10.1093/neuonc/noaa222.348 |
_version_ | 1783618990673756160 |
---|---|
author | Tam, Lydia Yecies, Derek Han, Michelle Toescu, Sebastien Wright, Jason Mankad, Kshitij Ho, Chang Lober, Robert Cheshier, Samuel Vitanza, Nick Fisher, Paul Hargrave, Darren Jacques, Tom Aquilina, Kristian Grant, Gerald Taylor, Michael Mattonen, Sarah Ramaswamy, Vijay Yeom, Kristen |
author_facet | Tam, Lydia Yecies, Derek Han, Michelle Toescu, Sebastien Wright, Jason Mankad, Kshitij Ho, Chang Lober, Robert Cheshier, Samuel Vitanza, Nick Fisher, Paul Hargrave, Darren Jacques, Tom Aquilina, Kristian Grant, Gerald Taylor, Michael Mattonen, Sarah Ramaswamy, Vijay Yeom, Kristen |
author_sort | Tam, Lydia |
collection | PubMed |
description | PURPOSE: Posterior fossa ependymomas (PFE) are common pediatric brain tumors often assessed with MRI before surgery. Advanced radiomic analysis show promise in stratifying risk and outcome in other pediatric brain tumors. Here, we extracted high-dimensional MRI features to identify prognostic, image-based, radiomics markers of PFE and compared its performance to clinical variables. METHODS: 93 children from five centers (median age=3.3yrs; 59 males; mean PFS=50mos) were included. Tumor volumes were manually contoured on T1-post contrast and T2-weighted MRI for PyRadiomics feature extraction. Features include first-order statistics, size, shape, and texture metrics calculated on the original, log-sigma, and wavelet transformed images. Progression free survival (PFS) served as outcome. 10-fold cross-validation of a LASSO Cox regression was used to predict PFS. Model performance was analyzed and concordance metric (C) was determined using clinical variable (age at diagnosis and sex) only, radiomics only, and radiomics plus clinical variable. RESULTS: Six radiomic features were selected (all T1): 1 first-order kurtosis (log-sigma) and 5 texture features (3 wavelet, 2 original). This model demonstrated significantly higher performance than a clinical model alone (C: 0.69 vs 0.58, p<0.001). Adding clinical features to the radiomic features didn’t improve prediction (p=0.67). For patients with molecular subtyping (n=48), adding this feature to the clinical plus radiomics models significantly improved performance over clinical features alone (C = 0.79 vs. 0.66, p=0.02). Further validation and model refinement with additional datasets are ongoing. CONCLUSION: Our pilot study shows potential role for MRI-based radiomics and machine learning for PFE risk stratification and as radiographic biomarkers. |
format | Online Article Text |
id | pubmed-7715588 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77155882020-12-09 IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA Tam, Lydia Yecies, Derek Han, Michelle Toescu, Sebastien Wright, Jason Mankad, Kshitij Ho, Chang Lober, Robert Cheshier, Samuel Vitanza, Nick Fisher, Paul Hargrave, Darren Jacques, Tom Aquilina, Kristian Grant, Gerald Taylor, Michael Mattonen, Sarah Ramaswamy, Vijay Yeom, Kristen Neuro Oncol Imaging PURPOSE: Posterior fossa ependymomas (PFE) are common pediatric brain tumors often assessed with MRI before surgery. Advanced radiomic analysis show promise in stratifying risk and outcome in other pediatric brain tumors. Here, we extracted high-dimensional MRI features to identify prognostic, image-based, radiomics markers of PFE and compared its performance to clinical variables. METHODS: 93 children from five centers (median age=3.3yrs; 59 males; mean PFS=50mos) were included. Tumor volumes were manually contoured on T1-post contrast and T2-weighted MRI for PyRadiomics feature extraction. Features include first-order statistics, size, shape, and texture metrics calculated on the original, log-sigma, and wavelet transformed images. Progression free survival (PFS) served as outcome. 10-fold cross-validation of a LASSO Cox regression was used to predict PFS. Model performance was analyzed and concordance metric (C) was determined using clinical variable (age at diagnosis and sex) only, radiomics only, and radiomics plus clinical variable. RESULTS: Six radiomic features were selected (all T1): 1 first-order kurtosis (log-sigma) and 5 texture features (3 wavelet, 2 original). This model demonstrated significantly higher performance than a clinical model alone (C: 0.69 vs 0.58, p<0.001). Adding clinical features to the radiomic features didn’t improve prediction (p=0.67). For patients with molecular subtyping (n=48), adding this feature to the clinical plus radiomics models significantly improved performance over clinical features alone (C = 0.79 vs. 0.66, p=0.02). Further validation and model refinement with additional datasets are ongoing. CONCLUSION: Our pilot study shows potential role for MRI-based radiomics and machine learning for PFE risk stratification and as radiographic biomarkers. Oxford University Press 2020-12-04 /pmc/articles/PMC7715588/ http://dx.doi.org/10.1093/neuonc/noaa222.348 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Imaging Tam, Lydia Yecies, Derek Han, Michelle Toescu, Sebastien Wright, Jason Mankad, Kshitij Ho, Chang Lober, Robert Cheshier, Samuel Vitanza, Nick Fisher, Paul Hargrave, Darren Jacques, Tom Aquilina, Kristian Grant, Gerald Taylor, Michael Mattonen, Sarah Ramaswamy, Vijay Yeom, Kristen IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA |
title | IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA |
title_full | IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA |
title_fullStr | IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA |
title_full_unstemmed | IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA |
title_short | IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA |
title_sort | img-13. mri-based radiomics prognostic markers of posterior fossa ependymoma |
topic | Imaging |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715588/ http://dx.doi.org/10.1093/neuonc/noaa222.348 |
work_keys_str_mv | AT tamlydia img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT yeciesderek img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT hanmichelle img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT toescusebastien img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT wrightjason img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT mankadkshitij img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT hochang img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT loberrobert img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT cheshiersamuel img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT vitanzanick img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT fisherpaul img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT hargravedarren img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT jacquestom img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT aquilinakristian img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT grantgerald img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT taylormichael img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT mattonensarah img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT ramaswamyvijay img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma AT yeomkristen img13mribasedradiomicsprognosticmarkersofposteriorfossaependymoma |